跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 49,162 条关于
“Gram-negative bacterial infections”
全部
49,162
临床试验
42,566
药物
858
机构
53
资讯
5,685
去年
Flightpath Biosciences Licenses Microbiome-Sparing Antibiotic Lolamicin for Gram-Negative Bacterial Infections
去年
Centauri Therapeutics Advances Novel Immunotherapy Against Gram-negative Bacterial Infections to Clinical Stage
去年
Shionogi's Cefiderocol Receives Priority Review in China for Gram-Negative Bacterial Infections
去年
Cefiderocol Shows Higher Efficacy When Used Earlier in Treatment of Serious Gram-Negative Infections
去年
Centauri Therapeutics Demonstrates Novel Immunotherapy Approach Against Multi-Drug Resistant Gram-Negative Infections
去年
Aztreonam-Avibactam Shows Promise Against Multidrug-Resistant Gram-Negative Infections
去年
Blacksmith Medicines Advances Novel Antibiotic FG-2101 Targeting Drug-Resistant Gram-Negative Bacteria
2个月前
FDA Accepts Shionogi's sNDA for Fetroja (Cefiderocol) in Pediatric Patients with Serious Gram-Negative Infections
去年
Shionogi's Antibiotic Fetroja Receives Marketing Approval in South Korea for Drug-Resistant Infections
去年
Prokaryotics Secures Global Rights to Novel Gram-Negative Antibiotic Potentiator NAB741
第 1 页,共 569 页
上一页
下一页